 | • レポートコード：D0GIR-00103 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、新型コロナウイルス感染症における化学薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。新型コロナウイルス感染症における化学薬品の種類別市場規模（レメドシビル、アルジドール、ファビピビル、ロピナビル/リトナビル（LPV / r）、クロロキン、その他）、用途別市場規模（新型コロナウイルス感染症、インフルエンザ、マラリア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Gilead Sciences、CSPC Pharmaceutical Group、Pfizer、AbbVie、Zhejiang Hisun、Johnson & Johnson、Sihuan Pharmaceutical、Bayer、Mylan、Reyoung Pharmaceutical、Guangzhou Baiyunshan Guanghua Pharmaceutical、Zhongsheng Pharma、Hikma Pharmaceuticals、KPC Group、Shanghai Pharma、Rising Pharmaceutical、North China Pharmaceutical Group、Jinghua Pharmaceutical Group、Sun Pharma ・地域別グローバル市場分析 2015年-2020年 ・新型コロナウイルス感染症における化学薬品の北米市場（アメリカ、カナダ、メキシコ） ・新型コロナウイルス感染症における化学薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・新型コロナウイルス感染症における化学薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・新型コロナウイルス感染症における化学薬品の南米市場（ブラジル、アルゼンチン） ・新型コロナウイルス感染症における化学薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：レメドシビル、アルジドール、ファビピビル、ロピナビル/リトナビル（LPV / r）、クロロキン、その他 ・用途別分析：新型コロナウイルス感染症、インフルエンザ、マラリア、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Chemical Medication in COVID-19 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Chemical Medication in COVID-19 sales will be xx in 2020 from Chemical Medication in COVID-19 million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Chemical Medication in COVID-19 market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Chemical Medication in COVID-19 industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Chemical Medication in COVID-19 and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Chemical Medication in COVID-19 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Chemical Medication in COVID-19 market has been segmented into:
Remedsivir
Ardidol
Favipivir
Lopinavir/ritonavir (LPV/r)
Chloroquine
Others
By Application, Chemical Medication in COVID-19 has been segmented into:
COVID-19
Influenza
Malaria
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chemical Medication in COVID-19 market presented in the report. This section sheds light on the sales growth of different regional and country-level Chemical Medication in COVID-19 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chemical Medication in COVID-19 market.
The report offers in-depth assessment of the growth and other aspects of the Chemical Medication in COVID-19 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Chemical Medication in COVID-19 Market Share Analysis
Chemical Medication in COVID-19 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chemical Medication in COVID-19 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chemical Medication in COVID-19 sales, revenue and market share for each player covered in this report.
The major players covered in Chemical Medication in COVID-19 are:
Gilead Sciences
CSPC Pharmaceutical Group
Pfizer
AbbVie
Zhejiang Hisun
Johnson & Johnson
Sihuan Pharmaceutical
Bayer
Mylan
Reyoung Pharmaceutical
Guangzhou Baiyunshan Guanghua Pharmaceutical
Zhongsheng Pharma
Hikma Pharmaceuticals
KPC Group
Shanghai Pharma
Rising Pharmaceutical
North China Pharmaceutical Group
Jinghua Pharmaceutical Group
Sun Pharma
Among other players domestic and global, Chemical Medication in COVID-19 market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Chemical Medication in COVID-19 Market Overview
1.1 Product Overview and Scope of Chemical Medication in COVID-19
1.2 Classification of Chemical Medication in COVID-19 by Type
1.2.1 Global Chemical Medication in COVID-19 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Chemical Medication in COVID-19 Revenue Market Share by Type in 2019
1.2.3 Remedsivir
1.2.4 Ardidol
1.2.5 Favipivir
1.2.6 Lopinavir/ritonavir (LPV/r)
1.2.7 Chloroquine
1.2.8 Others
1.3 Global Chemical Medication in COVID-19 Market by Application
1.3.1 Overview: Global Chemical Medication in COVID-19 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 COVID-19
1.3.3 Influenza
1.3.4 Malaria
1.3.5 Others
1.4 Global Chemical Medication in COVID-19 Market by Regions
1.4.1 Global Chemical Medication in COVID-19 Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Chemical Medication in COVID-19 (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Chemical Medication in COVID-19 Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Chemical Medication in COVID-19 Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chemical Medication in COVID-19 Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Chemical Medication in COVID-19 Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chemical Medication in COVID-19 Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Chemical Medication in COVID-19 Industry Impact
1.5.1 COVID-19 Potential Implications for the Chemical Medication in COVID-19
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Chemical Medication in COVID-19
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Gilead Sciences SWOT Analysis
2.1.4 Gilead Sciences Product and Services
2.1.5 Gilead Sciences Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.2 CSPC Pharmaceutical Group
2.2.1 CSPC Pharmaceutical Group Details
2.2.2 CSPC Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 CSPC Pharmaceutical Group SWOT Analysis
2.2.4 CSPC Pharmaceutical Group Product and Services
2.2.5 CSPC Pharmaceutical Group Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AbbVie SWOT Analysis
2.4.4 AbbVie Product and Services
2.4.5 AbbVie Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.5 Zhejiang Hisun
2.5.1 Zhejiang Hisun Details
2.5.2 Zhejiang Hisun Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Zhejiang Hisun SWOT Analysis
2.5.4 Zhejiang Hisun Product and Services
2.5.5 Zhejiang Hisun Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sihuan Pharmaceutical
2.7.1 Sihuan Pharmaceutical Details
2.7.2 Sihuan Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sihuan Pharmaceutical SWOT Analysis
2.7.4 Sihuan Pharmaceutical Product and Services
2.7.5 Sihuan Pharmaceutical Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer SWOT Analysis
2.8.4 Bayer Product and Services
2.8.5 Bayer Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mylan SWOT Analysis
2.9.4 Mylan Product and Services
2.9.5 Mylan Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.10 Reyoung Pharmaceutical
2.10.1 Reyoung Pharmaceutical Details
2.10.2 Reyoung Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Reyoung Pharmaceutical SWOT Analysis
2.10.4 Reyoung Pharmaceutical Product and Services
2.10.5 Reyoung Pharmaceutical Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.11 Guangzhou Baiyunshan Guanghua Pharmaceutical
2.11.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Details
2.11.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Guangzhou Baiyunshan Guanghua Pharmaceutical SWOT Analysis
2.11.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Product and Services
2.11.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.12 Zhongsheng Pharma
2.12.1 Zhongsheng Pharma Details
2.12.2 Zhongsheng Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Zhongsheng Pharma SWOT Analysis
2.12.4 Zhongsheng Pharma Product and Services
2.12.5 Zhongsheng Pharma Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.13 Hikma Pharmaceuticals
2.13.1 Hikma Pharmaceuticals Details
2.13.2 Hikma Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Hikma Pharmaceuticals SWOT Analysis
2.13.4 Hikma Pharmaceuticals Product and Services
2.13.5 Hikma Pharmaceuticals Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.14 KPC Group
2.14.1 KPC Group Details
2.14.2 KPC Group Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 KPC Group SWOT Analysis
2.14.4 KPC Group Product and Services
2.14.5 KPC Group Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.15 Shanghai Pharma
2.15.1 Shanghai Pharma Details
2.15.2 Shanghai Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Shanghai Pharma SWOT Analysis
2.15.4 Shanghai Pharma Product and Services
2.15.5 Shanghai Pharma Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.16 Rising Pharmaceutical
2.16.1 Rising Pharmaceutical Details
2.16.2 Rising Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Rising Pharmaceutical SWOT Analysis
2.16.4 Rising Pharmaceutical Product and Services
2.16.5 Rising Pharmaceutical Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.17 North China Pharmaceutical Group
2.17.1 North China Pharmaceutical Group Details
2.17.2 North China Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 North China Pharmaceutical Group SWOT Analysis
2.17.4 North China Pharmaceutical Group Product and Services
2.17.5 North China Pharmaceutical Group Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.18 Jinghua Pharmaceutical Group
2.18.1 Jinghua Pharmaceutical Group Details
2.18.2 Jinghua Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Jinghua Pharmaceutical Group SWOT Analysis
2.18.4 Jinghua Pharmaceutical Group Product and Services
2.18.3 Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.19 Sun Pharma
2.19.1 Sun Pharma Details
2.19.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Sun Pharma SWOT Analysis
2.19.4 Sun Pharma Product and Services
2.19.5 Sun Pharma Chemical Medication in COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Chemical Medication in COVID-19 Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Chemical Medication in COVID-19 Players Market Share
3.2.2 Top 10 Chemical Medication in COVID-19 Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Chemical Medication in COVID-19 Revenue and Market Share by Regions
4.2 North America Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
4.3 Europe Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
4.5 South America Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
5 North America Chemical Medication in COVID-19 Revenue by Countries
5.1 North America Chemical Medication in COVID-19 Revenue by Countries (2015-2020)
5.2 USA Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
5.3 Canada Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
5.4 Mexico Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
6 Europe Chemical Medication in COVID-19 Revenue by Countries
6.1 Europe Chemical Medication in COVID-19 Revenue by Countries (2015-2020)
6.2 Germany Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
6.3 UK Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
6.4 France Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
6.5 Russia Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
6.6 Italy Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Chemical Medication in COVID-19 Revenue by Countries
7.1 Asia-Pacific Chemical Medication in COVID-19 Revenue by Countries (2015-2020)
7.2 China Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
7.3 Japan Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
7.4 Korea Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
7.5 India Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
8 South America Chemical Medication in COVID-19 Revenue by Countries
8.1 South America Chemical Medication in COVID-19 Revenue by Countries (2015-2020)
8.2 Brazil Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
8.3 Argentina Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Chemical Medication in COVID-19 by Countries
9.1 Middle East & Africa Chemical Medication in COVID-19 Revenue by Countries (2015-2020)
9.2 Saudi Arabia Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
9.3 UAE Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
9.4 Egypt Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
9.5 South Africa Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Chemical Medication in COVID-19 Revenue and Market Share by Type (2015-2020)
10.2 Global Chemical Medication in COVID-19 Market Forecast by Type (2019-2024)
10.3 Remedsivir Revenue Growth Rate (2015-2025)
10.4 Ardidol Revenue Growth Rate (2015-2025)
10.5 Favipivir Revenue Growth Rate (2015-2025)
10.6 Lopinavir/ritonavir (LPV/r) Revenue Growth Rate (2015-2025)
10.7 Chloroquine Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Chemical Medication in COVID-19 Market Segment by Application
11.1 Global Chemical Medication in COVID-19 Revenue Market Share by Application (2015-2020)
11.2 Chemical Medication in COVID-19 Market Forecast by Application (2019-2024)
11.3 COVID-19 Revenue Growth (2015-2020)
11.4 Influenza Revenue Growth (2015-2020)
11.5 Malaria Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Chemical Medication in COVID-19 Market Size Forecast (2021-2025)
12.1 Global Chemical Medication in COVID-19 Market Size Forecast (2021-2025)
12.2 Global Chemical Medication in COVID-19 Market Forecast by Regions (2021-2025)
12.3 North America Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
12.4 Europe Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
12.6 South America Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Chemical Medication in COVID-19 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chemical Medication in COVID-19 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chemical Medication in COVID-19 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Chemical Medication in COVID-19 Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Chemical Medication in COVID-19 Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Gilead Sciences Corporate Information, Location and Competitors
Table 7. Gilead Sciences Chemical Medication in COVID-19 Major Business
Table 8. Gilead Sciences Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 9. Gilead Sciences SWOT Analysis
Table 10. Gilead Sciences Chemical Medication in COVID-19 Product and Solutions
Table 11. Gilead Sciences Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. CSPC Pharmaceutical Group Corporate Information, Location and Competitors
Table 13. CSPC Pharmaceutical Group Chemical Medication in COVID-19 Major Business
Table 14. CSPC Pharmaceutical Group Chemical Medication in COVID-19 Total Revenue (USD Million) (2018-2019)
Table 15. CSPC Pharmaceutical Group SWOT Analysis
Table 16. CSPC Pharmaceutical Group Chemical Medication in COVID-19 Product and Solutions
Table 17. CSPC Pharmaceutical Group Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Pfizer Corporate Information, Location and Competitors
Table 19. Pfizer Chemical Medication in COVID-19 Major Business
Table 20. Pfizer Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 21. Pfizer SWOT Analysis
Table 22. Pfizer Chemical Medication in COVID-19 Product and Solutions
Table 23. Pfizer Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. AbbVie Corporate Information, Location and Competitors
Table 25. AbbVie Chemical Medication in COVID-19 Major Business
Table 26. AbbVie Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 27. AbbVie SWOT Analysis
Table 28. AbbVie Chemical Medication in COVID-19 Product and Solutions
Table 29. AbbVie Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Zhejiang Hisun Corporate Information, Location and Competitors
Table 31. Zhejiang Hisun Chemical Medication in COVID-19 Major Business
Table 32. Zhejiang Hisun Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 33. Zhejiang Hisun SWOT Analysis
Table 34. Zhejiang Hisun Chemical Medication in COVID-19 Product and Solutions
Table 35. Zhejiang Hisun Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Johnson & Johnson Corporate Information, Location and Competitors
Table 37. Johnson & Johnson Chemical Medication in COVID-19 Major Business
Table 38. Johnson & Johnson Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 39. Johnson & Johnson SWOT Analysis
Table 40. Johnson & Johnson Chemical Medication in COVID-19 Product and Solutions
Table 41. Johnson & Johnson Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Sihuan Pharmaceutical Corporate Information, Location and Competitors
Table 43. Sihuan Pharmaceutical Chemical Medication in COVID-19 Major Business
Table 44. Sihuan Pharmaceutical Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 45. Sihuan Pharmaceutical SWOT Analysis
Table 46. Sihuan Pharmaceutical Chemical Medication in COVID-19 Product and Solutions
Table 47. Sihuan Pharmaceutical Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Bayer Corporate Information, Location and Competitors
Table 49. Bayer Chemical Medication in COVID-19 Major Business
Table 50. Bayer Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 51. Bayer SWOT Analysis
Table 52. Bayer Chemical Medication in COVID-19 Product and Solutions
Table 53. Bayer Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Mylan Corporate Information, Location and Competitors
Table 55. Mylan Chemical Medication in COVID-19 Major Business
Table 56. Mylan Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 57. Mylan SWOT Analysis
Table 58. Mylan Chemical Medication in COVID-19 Product and Solutions
Table 59. Mylan Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Reyoung Pharmaceutical Corporate Information, Location and Competitors
Table 61. Reyoung Pharmaceutical Chemical Medication in COVID-19 Major Business
Table 62. Reyoung Pharmaceutical Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 63. Reyoung Pharmaceutical SWOT Analysis
Table 64. Reyoung Pharmaceutical Chemical Medication in COVID-19 Product and Solutions
Table 65. Reyoung Pharmaceutical Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Information, Location and Competitors
Table 67. Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Major Business
Table 68. Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 69. Guangzhou Baiyunshan Guanghua Pharmaceutical SWOT Analysis
Table 70. Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Product and Solutions
Table 71. Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Zhongsheng Pharma Corporate Information, Location and Competitors
Table 73. Zhongsheng Pharma Chemical Medication in COVID-19 Major Business
Table 74. Zhongsheng Pharma Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 75. Zhongsheng Pharma SWOT Analysis
Table 76. Zhongsheng Pharma Chemical Medication in COVID-19 Product and Solutions
Table 77. Zhongsheng Pharma Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Hikma Pharmaceuticals Corporate Information, Location and Competitors
Table 79. Hikma Pharmaceuticals Chemical Medication in COVID-19 Major Business
Table 80. Hikma Pharmaceuticals Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 81. Hikma Pharmaceuticals SWOT Analysis
Table 82. Hikma Pharmaceuticals Chemical Medication in COVID-19 Product and Solutions
Table 83. Hikma Pharmaceuticals Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. KPC Group Corporate Information, Location and Competitors
Table 85. KPC Group Chemical Medication in COVID-19 Major Business
Table 86. KPC Group Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 87. KPC Group SWOT Analysis
Table 88. KPC Group Chemical Medication in COVID-19 Product and Solutions
Table 89. KPC Group Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Shanghai Pharma Corporate Information, Location and Competitors
Table 91. Shanghai Pharma Chemical Medication in COVID-19 Major Business
Table 92. Shanghai Pharma Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 93. Shanghai Pharma SWOT Analysis
Table 94. Shanghai Pharma Chemical Medication in COVID-19 Product and Solutions
Table 95. Shanghai Pharma Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Rising Pharmaceutical Corporate Information, Location and Competitors
Table 97. Rising Pharmaceutical Chemical Medication in COVID-19 Major Business
Table 98. Rising Pharmaceutical Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 99. Rising Pharmaceutical SWOT Analysis
Table 100. Rising Pharmaceutical Chemical Medication in COVID-19 Product and Solutions
Table 101. Rising Pharmaceutical Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. North China Pharmaceutical Group Corporate Information, Location and Competitors
Table 103. North China Pharmaceutical Group Chemical Medication in COVID-19 Major Business
Table 104. North China Pharmaceutical Group Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 105. North China Pharmaceutical Group SWOT Analysis
Table 106. North China Pharmaceutical Group Chemical Medication in COVID-19 Product and Solutions
Table 107. North China Pharmaceutical Group Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Type and Application
Table 109. Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Major Business
Table 110. Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 111. Jinghua Pharmaceutical Group SWOT Analysis
Table 112. Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Product and Solutions
Table 113. Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Sun Pharma Corporate Information, Location and Competitors
Table 115. Sun Pharma Chemical Medication in COVID-19 Major Business
Table 116. Sun Pharma Chemical Medication in COVID-19 Total Revenue (USD Million) (2017-2018)
Table 117. Sun Pharma SWOT Analysis
Table 118. Sun Pharma Chemical Medication in COVID-19 Product and Solutions
Table 119. Sun Pharma Chemical Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Global Chemical Medication in COVID-19 Revenue (Million USD) by Players (2015-2020)
Table 121. Global Chemical Medication in COVID-19 Revenue Share by Players (2015-2020)
Table 122. Global Chemical Medication in COVID-19 Revenue (Million USD) by Regions (2015-2020)
Table 123. Global Chemical Medication in COVID-19 Revenue Market Share by Regions (2015-2020)
Table 124. North America Chemical Medication in COVID-19 Revenue by Countries (2015-2020)
Table 125. North America Chemical Medication in COVID-19 Revenue Market Share by Countries (2015-2020)
Table 126. Europe Chemical Medication in COVID-19 Revenue (Million USD) by Countries (2015-2020)
Table 127. Asia-Pacific Chemical Medication in COVID-19 Revenue (Million USD) by Countries (2015-2020)
Table 128. South America Chemical Medication in COVID-19 Revenue by Countries (2015-2020)
Table 129. South America Chemical Medication in COVID-19 Revenue Market Share by Countries (2015-2020)
Table 130. Middle East and Africa Chemical Medication in COVID-19 Revenue (Million USD) by Countries (2015-2020)
Table 131. Middle East and Africa Chemical Medication in COVID-19 Revenue Market Share by Countries (2015-2020)
Table 132. Global Chemical Medication in COVID-19 Revenue (Million USD) by Type (2015-2020)
Table 133. Global Chemical Medication in COVID-19 Revenue Share by Type (2015-2020)
Table 134. Global Chemical Medication in COVID-19 Revenue Forecast by Type (2021-2025)
Table 135. Global Chemical Medication in COVID-19 Revenue by Application (2015-2020)
Table 136. Global Chemical Medication in COVID-19 Revenue Share by Application (2015-2020)
Table 137. Global Chemical Medication in COVID-19 Revenue Forecast by Application (2021-2025)
Table 138. Global Chemical Medication in COVID-19 Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Chemical Medication in COVID-19 Picture
Figure 2. Global Chemical Medication in COVID-19 Revenue Market Share by Type in 2019
Figure 3. Remedsivir Picture
Figure 4. Ardidol Picture
Figure 5. Favipivir Picture
Figure 6. Lopinavir/ritonavir (LPV/r) Picture
Figure 7. Chloroquine Picture
Figure 8. Others Picture
Figure 9. Chemical Medication in COVID-19 Revenue Market Share by Application in 2019
Figure 10. COVID-19 Picture
Figure 11. Influenza Picture
Figure 12. Malaria Picture
Figure 13. Others Picture
Figure 14. Global Chemical Medication in COVID-19 Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Chemical Medication in COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Chemical Medication in COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Chemical Medication in COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Chemical Medication in COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Chemical Medication in COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Chemical Medication in COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Chemical Medication in COVID-19 Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Chemical Medication in COVID-19 Revenue Market Share in 2019
Figure 23. Global Top 10 Players Chemical Medication in COVID-19 Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Chemical Medication in COVID-19 Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Chemical Medication in COVID-19 Revenue Market Share by Regions (2015-2020)
Figure 27. Global Chemical Medication in COVID-19 Revenue Market Share by Regions in 2018
Figure 28. North America Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 29. Europe Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 31. South America Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 33. North America Chemical Medication in COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 34. North America Chemical Medication in COVID-19 Revenue Market Share by Countries in 2019
Figure 35. USA Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 36. Canada Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 38. Europe Chemical Medication in COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Chemical Medication in COVID-19 Revenue Market Share by Countries in 2019
Figure 40. Germany Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 41. UK Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 42. France Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 43. Russia Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 44. Italy Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Chemical Medication in COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Chemical Medication in COVID-19 Revenue Market Share by Countries in 2019
Figure 47. China Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 48. Japan Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 49. Korea Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 50. India Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 52. South America Chemical Medication in COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 53. South America Chemical Medication in COVID-19 Revenue Market Share by Countries in 2019
Figure 54. Brazil Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Chemical Medication in COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Chemical Medication in COVID-19 Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 59. UAE Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Chemical Medication in COVID-19 Revenue and Growth Rate (2015-2020)
Figure 62. Global Chemical Medication in COVID-19 Revenue Share by Type (2015-2020)
Figure 63. Global Chemical Medication in COVID-19 Revenue Share by Type in 2019
Figure 64. Global Chemical Medication in COVID-19 Market Share Forecast by Type (2021-2025)
Figure 65. Global Remedsivir Revenue Growth Rate (2015-2020)
Figure 66. Global Ardidol Revenue Growth Rate (2015-2020)
Figure 67. Global Favipivir Revenue Growth Rate (2015-2020)
Figure 68. Global Lopinavir/ritonavir (LPV/r) Revenue Growth Rate (2015-2020)
Figure 69. Global Chloroquine Revenue Growth Rate (2015-2020)
Figure 70. Global Others Revenue Growth Rate (2015-2020)
Figure 71. Global Chemical Medication in COVID-19 Revenue Share by Application (2015-2020)
Figure 72. Global Chemical Medication in COVID-19 Revenue Share by Application in 2019
Figure 73. Global Chemical Medication in COVID-19 Market Share Forecast by Application (2021-2025)
Figure 74. Global COVID-19 Revenue Growth Rate (2015-2020)
Figure 75. Global Influenza Revenue Growth Rate (2015-2020)
Figure 76. Global Malaria Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Chemical Medication in COVID-19 Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Chemical Medication in COVID-19 Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Chemical Medication in COVID-19 Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
Figure 82. Europe Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
Figure 84. South America Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Chemical Medication in COVID-19 Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
新型コロナウイルス感染症における生物学的製剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Biologic Medication in COVID-19 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 痤瘡治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Acne Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7718.3 million by 2025, from USD 7098.1 million in 2019. The Acne Medication mark…
- 注射型鎮痛薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Injectable Pain Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 市販用鎮痛剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Over-the-Counter Pain Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Over-the-Cou…
- インフルエンザ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Influenza Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 654.9 million by 2025, from USD 545.7 million in 2019. The Influenza Medicat…